Schedule & Program

2018 Keynote Speakers:

2018 Event Program.pdf

SCHEDULE

7:00-8:15am  Continental Breakfast

8:15-8:25am  Opening Remarks: Jon Soderstrom, Managing Director, Yale Office of Cooperative Research

8:25-9:00am  Keynote: “Transforming Healthcare: Personal Genomes to AI Enabled Ultrasound on a Chip”
Jonathan Rothberg, Chief Strategy Office, 4Catalyzer & Inventor of High-Speed DNA Sequencing
Introduction: Michael Crair, Yale

9:05-10:05am (Biotech Track, Zhang Auditorium)
China & Asia: Future Opportunities for Advancing Biotech

9:05-10:05am (Tech Track, Room 2400)
Building a Quantum Computer – Can a Yale Startup Lead the Next Generation in Computing?

10:10-11:00am (Biotech Track, Zhang Auditorium)
Trends in Biotech Investing

10:10-11:00am (Tech Track, Room 2400)
Blockchain & Internet Security – What Does the Future Hold?
11:00am-12:30pm  Lunch & ePoster Session & Presentations (Courtyard)

12:30-1:30pm  Biotech Pitch Contest (Zhang Auditorium)
Moderator: Rob Bettigole,
Elm Street Ventures

Pacific Oncovirus – Lassa-VSV targets and eliminates brain cancer
Team: Anthony van den Pol

Vittix Therapeutics – Curing idiopathic pulmonary fibrosis with thyroid hormone mimetics
Team: Naftali Kaminski, Milica Vukmirovic

NASHTherapeutics – Clinical development of a compound for non-alcoholic steatohepatitis, the most common liver disease in the US
Team: Wajahat Mehal

Center Pharm – NCS1 – a new target for Wolfram syndrome
Team: Barbara Ehrlich

Domillin – Keeping the antibiotic miracle alive
Team: Mark Plummer

EvolveImmune – Novel platform technologies and targets for development of new cancer (immuno-) therapies
Team: Sidi Chen, Charles Fuchs

Paci-PHI – Evolution-proof therapy against multi-drug resistant bacterial pathogens
Team: Paul Turner, Benjamin Chan

Innatia – RIG-I agonists as next-gen immunotherapies
Team: Anna Pyle, Akiko Iwasaki

12:30-1:30pm  Tech Pitch Contest (Room 2400)
Moderator: Monica Kolinsky,
Wiggin and Dana

PremieBreathe – Low-cost breathing aid for newborns
Team: Anjelica Gonzalez

SOL – The new face of mental health
Team: Nicholas Chedid

HybriTech – Hybrid technologies for cereal crops
Team: Maria Moreno

Proteowise – Rapid, low cost, multiplexed, bench-top proteomics
Team: Erik Gunther, Mikhail Kostylev, Stephen Strittmatter

Expect With Me – Revolutionizing health care by reducing costs and improving outcomes
Team: Jessica Lewis, Jeannette Ickovics

CORISMA – Novel cardiac device bridges critical treatment gap
Team: Jiheum Park, Pramod Bonde

RE3MMUNE – A genetics-free approach to producing potent T cells in a bedside manner for cancer, autoimmunity and infections
Team: Tarek Fahmy

Nth Cycle – Providing a secure supply of rare earth and specialty metals for advanced electronics
Team: Desirée Plata, Megan O’Connor

1:35-2:30pm (Biotech Track, Zhang Auditorium)
Biotech Startup Ecosystems


1:35-2:30pm (Tech Track, Room 2400)
Challenges in Implementing Innovation

2:30-3:00pm: Coffee Break

3:00-3:40pm  Keynote: “New Paradigm of Translational Research”
Yibing Wu
, Joint Head, Portfolio Strategy & Risk Group, Temasek China
Introduction
: Haifan Lin, Yale

3:45-4:20pm  Keynote: “Passing the Torch”
Arie Belldegrun
, Leading Biotech Researcher, Entrepreneur & Investor with Kite Pharma and Vida Ventures
Introduction: Sean Mackay, Isoplexis

4:25-5:00pm  Closing Remarks and Announcement of Pitch Contest Winners and Blavatnik Awards

5:00-7:30pm  Post-Event Reception at the Peabody Museum Sponsored by Wiggin and Dana

Additional Opportunity Available All Day

Dr. Greg Evans from the National Cancer Institute (NCI) will be attending the Yale Innovation Summit and will be available throughout the conference to meet individually with any Yale faculty or investors interested in learning about or seeking SBIR (Small Business Innovation Research) or STTR (Small Business Technology Transfer Research) funding from the National Cancer Institute. Greg will be available to discuss 4 core SBIR award mechanisms for very early stage to late-stage oncology product development efforts, including a private sector matching fund program for late-stage products that offers up to $4 Million from NCI, plus the match. All oncology product types are welcome. Greg will be available to discuss optimal research scope and strategies to build competitive funding applications for the NCI small business programs, to support bringing new cancer science to the market. University faculty entrepreneurs and investors are welcome. NCI SBIR/STTR Program background. If interested in meeting with Greg, please contact him directly at evansgl@mail.nih.gov or 240-276-5245.